Nanomedicines enhance minimally invasive therapy of pancreatic cancer
Pancreatic carcinoma (PCa) is a malignant tumor that is highly lethal and lacks an effective
treatment. Although surgical treatment, chemotherapy, and radiotherapy of PCa have …
treatment. Although surgical treatment, chemotherapy, and radiotherapy of PCa have …
Multimodal therapies against pancreatic ductal adenocarcinoma: a review on synergistic approaches toward ultimate nanomedicine treatments
M Conte, V Cauda - Advanced Therapeutics, 2022 - Wiley Online Library
In the last decades, extensive research has been carried out on the understanding and
treatment of pancreatic cancer. Despite the significant advances in medicine and …
treatment of pancreatic cancer. Despite the significant advances in medicine and …
Targeted delivery and anticancer effects of Chrysin-loaded chitosan-folic acid coated solid lipid nanoparticles in pancreatic malignant cells
A Farhadi, M Homayouni Tabrizi… - Journal of …, 2023 - Taylor & Francis
The aim of this survey was to load Chrysin (CHY) on solid lipid nanoparticles (SLNs) and
decorate the nanoparticles with folate-bound chitosan to increase the effectiveness of the …
decorate the nanoparticles with folate-bound chitosan to increase the effectiveness of the …
Recent advancements in developing nanobiosensors for treating inflammatory diseases of human: a comprehensive overview
A Chakraborty, S Mitra, M Chatterjee, A Dey… - … of Biotribology in …, 2024 - Springer
Nanobiosensor has been the major advantageous modification of conventional biosensing
devices for meeting the needs of advanced diagnosis and treatment of several complicated …
devices for meeting the needs of advanced diagnosis and treatment of several complicated …
Implications of cancer stem cells in diabetes and pancreatic cancer
AG Mukherjee, UR Wanjari, AV Gopalakrishnan… - Life Sciences, 2023 - Elsevier
This review provides a detailed study of pancreatic cancer (PC) and the implication of
different types of cancers concerning diabetes. The combination of anti-diabetic drugs with …
different types of cancers concerning diabetes. The combination of anti-diabetic drugs with …
New insights into the biological response triggered by dextran-coated maghemite nanoparticles in pancreatic cancer cells and their potential for theranostic …
M Balas, D Predoi, C Burtea, A Dinischiotu - International Journal of …, 2023 - mdpi.com
Iron oxide nanoparticles are one of the most promising tools for theranostic applications of
pancreatic cancer due to their unique physicochemical and magnetic properties making …
pancreatic cancer due to their unique physicochemical and magnetic properties making …
Metabolism and structure of PDA as the target for new therapies: possibilities and limitations for nanotechnology
A Zygmunt, J Gubernator - Expert Opinion on Drug Delivery, 2024 - Taylor & Francis
Introduction Certainly, pancreatic ductal adenocarcinoma poses one of the greatest
challenges in current oncology. The dense extracellular matrix and low vessel density in …
challenges in current oncology. The dense extracellular matrix and low vessel density in …
Strategies for drug targeting in pancreatic cancer
N Sharma, V Arora - Pancreatology, 2022 - Elsevier
Background Pancreatic cancer is expected to replace lung cancer as the second greatest
cause of cancer mortality by 2025. It has been a particularly the most lethal kind of cancer …
cause of cancer mortality by 2025. It has been a particularly the most lethal kind of cancer …
[HTML][HTML] CKS1B as a potential target for prognostic assessment and intervention in pancreatic cancer and its role in abnormal proliferation and cellular phenotype …
Y Tang, X Lan, M Yan, Z Fu, H Li - Saudi Medical Journal, 2024 - ncbi.nlm.nih.gov
Objectives: To investigate the role of cell cycle protein-dependent kinase regulatory subunit
1B (CKS1B) in driving the aggressive and rapid proliferation observed in pancreatic cancer …
1B (CKS1B) in driving the aggressive and rapid proliferation observed in pancreatic cancer …